Nuzenio

Marketbeat Ultragenyx Pharmaceutical

Marketbeat Ultragenyx Pharmaceutical entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 15 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Ultragenyx Pharmaceutical's (RARE) Buy Rating Reiterated at HC Wainwright - MarketBeatMarketBeat · Mon, 10 Aug 2026 12:23:46 GMTSei Investments Co. Sells 61,632 Shares of Ultragenyx Pharmaceutical Inc. $RARE - MarketBeatMarketBeat · Mon, 10 Aug 2026 08:46:59 GMTQuantinno Capital Management LP Purchases 137,758 Shares of Ultragenyx Pharmaceutical Inc. $RARE - MarketBeatMarketBeat · Sat, 08 Aug 2026 09:15:09 GMTUltragenyx Pharmaceutical (NASDAQ:RARE) Stock Rating Upgraded by Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 06:05:03 GMTUltragenyx Pharmaceutical Inc. (NASDAQ:RARE) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeatMarketBeat · Fri, 07 Aug 2026 08:32:34 GMTUltragenyx Pharmaceutical (NASDAQ:RARE) Price Target Cut to $45.00 by Analysts at Wells Fargo & Company - MarketBeatMarketBeat · Wed, 05 Aug 2026 16:01:50 GMTUltragenyx Pharmaceutical (NASDAQ:RARE) Shares Gap Up on Strong Earnings - MarketBeatMarketBeat · Wed, 05 Aug 2026 14:42:21 GMTUltragenyx Pharmaceutical Q2 Earnings Call Highlights - MarketBeatMarketBeat · Wed, 05 Aug 2026 02:23:40 GMT

Timeline

Mon, 10 Aug 2026 12:23:46 GMTUltragenyx Pharmaceutical's (RARE) Buy Rating Reiterated at HC Wainwright - MarketBeat
Mon, 10 Aug 2026 08:46:59 GMTSei Investments Co. Sells 61,632 Shares of Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat
Sat, 08 Aug 2026 09:15:09 GMTQuantinno Capital Management LP Purchases 137,758 Shares of Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat
Sat, 08 Aug 2026 06:05:03 GMTUltragenyx Pharmaceutical (NASDAQ:RARE) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Fri, 07 Aug 2026 08:32:34 GMTUltragenyx Pharmaceutical Inc. (NASDAQ:RARE) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Wed, 05 Aug 2026 16:01:50 GMTUltragenyx Pharmaceutical (NASDAQ:RARE) Price Target Cut to $45.00 by Analysts at Wells Fargo & Company - MarketBeat

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Marketbeat Ultragenyx Pharmaceutical.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.